# A Study Evaluating the Effect of Esomeprazole on SYN-004 Degradation of Ceftriaxone In Adults With an Ileostomy

> **NCT02473640** · PHASE1,PHASE2 · COMPLETED · sponsor: **Theriva Biologics, Inc.** · enrollment: 15 (actual)

## Conditions studied

- Healthy Volunteers With Ileostomy

## Interventions

- **DRUG:** SYN-004
- **DRUG:** Esomeprazole
- **DRUG:** Ceftriaxone

## Key facts

- **NCT ID:** NCT02473640
- **Lead sponsor:** Theriva Biologics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2018-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02473640

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02473640, "A Study Evaluating the Effect of Esomeprazole on SYN-004 Degradation of Ceftriaxone In Adults With an Ileostomy". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT02473640. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*